Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

Claire N. Harrison; Martin Griesshammer; Carole Miller; Tamas Masszi; Francesco Passamonti; Pierre Zachee; Simon Durrant; Fabrizio Pane; Paola Guglielmelli; Srdan Verstovsek; Mark M. Jones; Deborah S. Hunter; William Sun; Jingjin Li; Mahmudul Khan; Dany Habr; Jean Jacques Kiladjian

doi:10.1111/bjh.14764

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

Claire N. Harrison, Martin Griesshammer, Carole Miller, Tamas Masszi, Francesco Passamonti, Pierre Zachee, Simon Durrant, Fabrizio Pane, Paola Guglielmelli, Srdan Verstovsek, Mark M. Jones, Deborah S. Hunter, William Sun, Jingjin Li, Mahmudul Khan, Dany Habr, Jean Jacques Kiladjian

Leukemia

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	279-284
Number of pages	6
Journal	British Journal of Haematology
Volume	182
Issue number	2
DOIs	https://doi.org/10.1111/bjh.14764
State	Published - Jul 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.14764

Cite this

Harrison, C. N., Griesshammer, M., Miller, C., Masszi, T., Passamonti, F., Zachee, P., Durrant, S., Pane, F., Guglielmelli, P., Verstovsek, S., Jones, M. M., Hunter, D. S., Sun, W., Li, J., Khan, M., Habr, D., & Kiladjian, J. J. (2018). Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide. British Journal of Haematology, 182(2), 279-284. https://doi.org/10.1111/bjh.14764

Harrison, CN, Griesshammer, M, Miller, C, Masszi, T, Passamonti, F, Zachee, P, Durrant, S, Pane, F, Guglielmelli, P, Verstovsek, S, Jones, MM, Hunter, DS, Sun, W, Li, J, Khan, M, Habr, D & Kiladjian, JJ 2018, 'Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide', British Journal of Haematology, vol. 182, no. 2, pp. 279-284. https://doi.org/10.1111/bjh.14764

@article{475abb892c7249d1a7221f99c45aa2d3,

title = "Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide",

author = "Harrison, {Claire N.} and Martin Griesshammer and Carole Miller and Tamas Masszi and Francesco Passamonti and Pierre Zachee and Simon Durrant and Fabrizio Pane and Paola Guglielmelli and Srdan Verstovsek and Jones, {Mark M.} and Hunter, {Deborah S.} and William Sun and Jingjin Li and Mahmudul Khan and Dany Habr and Kiladjian, {Jean Jacques}",

note = "Funding Information: The authors thank Ahmad Naim and Brian Gadbaw for their helpful contributions to data analysis and interpretation. Dany Habr is currently an employee of AbbVie Inc, North Chicago, IL, USA, but was employed by Novartis at time of manuscript development. Medical editorial assistance was provided by Karen Chinchilla, PhD (ArticulateScience LLC, Hamilton, NJ, USA), and funded by Novartis Pharmaceuticals Corporation.",

year = "2018",

month = jul,

doi = "10.1111/bjh.14764",

language = "English (US)",

volume = "182",

pages = "279--284",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

AU - Harrison, Claire N.

AU - Griesshammer, Martin

AU - Miller, Carole

AU - Masszi, Tamas

AU - Passamonti, Francesco

AU - Zachee, Pierre

AU - Durrant, Simon

AU - Pane, Fabrizio

AU - Guglielmelli, Paola

AU - Verstovsek, Srdan

AU - Jones, Mark M.

AU - Hunter, Deborah S.

AU - Sun, William

AU - Li, Jingjin

AU - Khan, Mahmudul

AU - Habr, Dany

AU - Kiladjian, Jean Jacques

N1 - Funding Information: The authors thank Ahmad Naim and Brian Gadbaw for their helpful contributions to data analysis and interpretation. Dany Habr is currently an employee of AbbVie Inc, North Chicago, IL, USA, but was employed by Novartis at time of manuscript development. Medical editorial assistance was provided by Karen Chinchilla, PhD (ArticulateScience LLC, Hamilton, NJ, USA), and funded by Novartis Pharmaceuticals Corporation.

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85019620539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019620539&partnerID=8YFLogxK

U2 - 10.1111/bjh.14764

DO - 10.1111/bjh.14764

M3 - Letter

C2 - 29984424

AN - SCOPUS:85019620539

SN - 0007-1048

VL - 182

SP - 279

EP - 284

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this